Emerging Transfusion Diagnostic Typing, Grouping and NAT Screening Tests, Country Market Shares, Strategic Profiles and Leading Reagent and Instrument Suppliers, 2019

Emerging Transfusion Diagnostic Typing, Grouping and NAT Screening Tests, Country Market Shares, Strategic Profiles and Leading Reagent and Instrument Suppliers, 2019

  • July 2019 •
  • 225 pages •
  • Report ID: 5795991 •
  • Format: PDF
Emerging Transfusion Diagnostic Typing, Grouping and NAT Screening Tests, Country Market Shares, Strategic Profiles and Leading Reagent and Instrument Suppliers, 2019

This 225-page report presents a comprehensive analysis of the clinical significance and market needs for major transfusion diagnostic typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing innovative blood banking technologies and products.

The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in RandD, collaborative arrangements, and business strategies.

Contains 225 pages and 6 tables


Companies Profiled
Competitive Assessments

- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Diagast
- DiaSorin
- Fujirebio
- Grifols
- Hologic
- Immucor
- LabCorp
- Ortho-Clinical Diagnostics
- Proteome Sciences
- Quest Diagnostics
- Quidel
- Roche
- Siemens Healthineers
- Tecan
- Thermo Fisher